Does thyrotoxic periodic paralysis have a genetic predisposition? A case report.

Area of Science:

• Endocrinology
• Neurology
• Genetics

Background:

• Thyrotoxic periodic paralysis (TPP) is a rare complication of hyperthyroidism characterized by hypokalemia and paralysis.
• It is increasingly reported in Caucasian populations, suggesting a broader genetic or environmental influence.
• TPP is considered a channelopathy, potentially involving defects in ion transport proteins like the sodium-potassium (Na/K-ATPase) pump.

Purpose of the Study:

• To investigate the genetic underpinnings of thyrotoxic periodic paralysis in a Caucasian patient.
• To identify potential genetic variants in candidate genes associated with periodic paralysis and thyroid hormone sensitivity.
• To explore the role of genetic factors and environmental triggers in the pathogenesis of TPP.

Main Methods:

• Case report of a 27-year-old Caucasian Irish male presenting with acute limb paralysis and hypokalemia.
• Diagnosis of TPP secondary to Graves' disease confirmed by clinical presentation, biochemistry, and response to potassium.
• Genetic analysis of candidate genes (KCNJ18, SCN4A, CACNA1S, Na/K-ATPase) for variants.

Main Results:

• The patient presented with classic symptoms of TPP and was diagnosed with Graves' disease.
• Genetic analysis revealed heterozygous variants in KCNJ18, SCN4A, and CACNA1S.
• These identified variants are common in the general population and do not fully explain the patient's phenotype.

Conclusions:

• The identified common genetic variants do not appear to be the primary cause of TPP in this patient.
• Acquired environmental factors or unidentified genetic mutations likely play a significant role in TPP pathogenesis.
• Further research is needed to elucidate the complex interplay of genetics and environment in thyrotoxic periodic paralysis.